ENTITY
Yichang HEC Changjiang Pharma

Yichang HEC Changjiang Pharma (1558 HK)

122
Analysis
Health CareHong Kong
YiChang HEC ChangJiang Pharmaceutical Co Ltd develops a variety of drugs. The Company develops and sells drugs for anti-virus, metabolic diseases, cardiovascular, and more.
more
07 Jul 2025 06:15

Fengxiang (9977 HK): Composite Doc Out. 24th July H-Class Meeting

This is done. But this is an illiquid arb - and Hong Kong has seen two failed small-cap Schemes recently. Plus PAG is inviting dissent after...

Logo
305 Views
Share
07 Jul 2025 01:21

Merger Arb Mondays (07 Jul) - Seven & I, Shibaura, Insignia, New World, ENN Energy, HKBN, Fengxiang

I summarise the latest spreads and newsflow of merger arb situations we cover across Hong Kong, Australia, New Zealand, Singapore, Japan,...

Logo
878 Views
Share
bullishLens Technology
06 Jul 2025 15:46

Weekly Deals Digest (06 Jul) - Lens Tech, FWD, Geekplus, NTT DC REIT, Fengxiang, HKBN, Insignia

A weekly summary of key developments across ECM and Event-Driven names tracked by us across Hong Kong, Australia, NZ, Singapore, Japan, Indonesia,...

Logo
515 Views
Share
06 Jul 2025 06:20

Last Week In Event SPACE: Shibaura, HKBN, NWD, Yichang HEC

It’s Sunday! Pour yourself a coffee, grab a comfortable seat, and sift through a brief summary of insights on various events discussed during the...

Logo
540 Views
Share
bullishNissin Corp
06 Jul 2025 06:15

(Mostly) Asia-Pac M&A: Talkmed, Jilin Jiutai Bank, Insignia, Silk Logistics, Fengxiang, Nissin, VIOL

This insight provides a summary of gross/annualised spreads (on deals discussed on Smartkarma) across Asia-Pacific as at the last trading date, and...

Logo
537 Views
Share
x